Senescence-associated ribosome biogenesis defects contributes to cell cycle arrest through the Rb pathway.
Frédéric LessardSebastian IgelmannChristian TrahanGeneviève HuotEmmanuelle Saint-GermainLian MignaccaNeylen Del ToroStéphane Lopes-PacienciaBenjamin Le CalvéMarinieve MonteroXavier Deschênes-SimardMarina BuryOlga MoiseevaMarie-Camille RowellCornelia E ZorcaDaniel R ZenklusenLéa Brakier-GingrasVéronique BourdeauMarlene OeffingerGerardo FerbeyrePublished in: Nature cell biology (2018)
Cellular senescence is a tumour suppressor programme characterized by a stable cell cycle arrest. Here we report that cellular senescence triggered by a variety of stimuli leads to diminished ribosome biogenesis and the accumulation of both rRNA precursors and ribosomal proteins. These defects were associated with reduced expression of several ribosome biogenesis factors, the knockdown of which was also sufficient to induce senescence. Genetic analysis revealed that Rb but not p53 was required for the senescence response to altered ribosome biogenesis. Mechanistically, the ribosomal protein S14 (RPS14 or uS11) accumulates in the soluble non-ribosomal fraction of senescent cells, where it binds and inhibits CDK4 (cyclin-dependent kinase 4). Overexpression of RPS14 is sufficient to inhibit Rb phosphorylation, inducing cell cycle arrest and senescence. Here we describe a mechanism for maintaining the senescent cell cycle arrest that may be relevant for cancer therapy, as well as biomarkers to identify senescent cells.
Keyphrases
- cell cycle arrest
- cell death
- pi k akt
- dna damage
- endothelial cells
- stress induced
- cancer therapy
- signaling pathway
- cell proliferation
- randomized controlled trial
- oxidative stress
- cell cycle
- protein kinase
- clinical trial
- binding protein
- study protocol
- transcription factor
- small molecule
- single cell
- endoplasmic reticulum stress